Klebs Research Center, Department of Dermatology, Yanbian University Hospital, Yanji, 133000, China.
BMC Med Genomics. 2021 Oct 2;14(1):239. doi: 10.1186/s12920-021-01087-7.
Keloid is a benign fibro-proliferative dermal tumor formed by an abnormal scarring response to injury and characterized by excessive collagen accumulation and invasive growth. The mechanism of keloid formation has not been fully elucidated, especially during abnormal scarring. Here, we investigated the regulatory genes, micro-RNAs (miRNAs) and transcription factors (TFs) that influence keloid development by comparing keloid and normal scar as well as keloid and normal skin.
Gene expression profiles (GSE7890, GSE92566, GSE44270 and GSE3189) of 5 normal scar samples, 10 normal skin samples and 18 keloid samples from the Gene Expression Omnibus (GEO) database were interrogated. Differentially expressed genes (DEGs) were identified between keloid and normal skin samples as well as keloid and normal scar samples with R Project for Statistical Computing. Gene Ontology (GO) functional enrichment analysis was also performed with R software. DEG-associated protein-protein interaction (PPI) network was constructed by STRING, followed by module selection from the PPI network based on the MCODE analysis. Regulatory relationships between TF/miRNA and target genes were predicted with miRnet and cytoscape. Core regulatory genes were verified by RT-qPCR.
We identified 628 DEGs, of which 626 were up-regulated and 2 were down-regulated. Seven core genes [neuropeptide Y(NPY), 5-hydroxytryptamine receptor 1A(HTR1A), somatostatin (SST), adenylate cyclase 8 (ADCY8), neuromedin U receptor 1 (NMUR1), G protein subunit gamma 3 (GNG3), and G protein subunit gamma 13 (GNG13)] all belong to MCODE1 and were enriched in the "G protein coupled receptor signaling pathway" of the GO biological process category. Furthermore, nine core miRNAs (hsa-mir-124, hsa-let-7, hsa-mir-155, hsa-mir-26a, hsa-mir-941, hsa-mir-10b, hsa-mir-20, hsa-mir-31 and hsa-mir-372), and two core TFs (SP1 and TERT) were identified to play important roles in keloid formation. In the TF/miRNA-target gene network, both hsa-mir-372 and hsa-mir-20 had a regulatory effect on GNG13, ADCY8 was predicted to be target by hsa-mir-10b, and HTR1A and NPY were potentially by SP1. Furthermore, the expression of core regulatory genes (GNG13, ADCY8, HTR1A and NPY) was validated in clinical samples.
GNG13, ADCY8, NPY and HTR1A may act as core genes in keloid formation and these core genes establish relationship with SP1 and miRNA (hsa-mir-372, hsa-mir-20, hsa-mir-10b), which may influence multiple signaling pathways in the pathogenesis of keloid.
瘢痕疙瘩是一种由创伤引起的异常瘢痕反应形成的良性纤维增生性真皮肿瘤,其特征是胶原过度积累和侵袭性生长。瘢痕疙瘩形成的机制尚未完全阐明,特别是在异常瘢痕形成过程中。在这里,我们通过比较瘢痕疙瘩和正常瘢痕以及瘢痕疙瘩和正常皮肤,研究了影响瘢痕疙瘩发育的调节基因、微小 RNA(miRNA)和转录因子(TF)。
从基因表达综合数据库(GEO)中检索了 5 个正常瘢痕样本、10 个正常皮肤样本和 18 个瘢痕疙瘩样本的基因表达谱(GSE7890、GSE92566、GSE44270 和 GSE3189)。使用 R 项目进行统计计算,在瘢痕疙瘩和正常皮肤样本以及瘢痕疙瘩和正常瘢痕样本之间确定差异表达基因(DEGs)。使用 R 软件进行基因本体论(GO)功能富集分析。通过 STRING 构建 DEG 相关蛋白-蛋白相互作用(PPI)网络,然后根据 MCODE 分析从 PPI 网络中选择模块。使用 miRnet 和 cytoscape 预测 TF/miRNA 与靶基因之间的调节关系。通过 RT-qPCR 验证核心调控基因。
我们鉴定了 628 个 DEGs,其中 626 个上调,2 个下调。7 个核心基因[神经肽 Y(NPY)、5-羟色胺受体 1A(HTR1A)、生长抑素(SST)、腺苷酸环化酶 8(ADCY8)、神经肽 U 受体 1(NMUR1)、G 蛋白亚基γ 3(GNG3)和 G 蛋白亚基γ 13(GNG13)]均属于 MCODE1,并且在 GO 生物过程类别中的“G 蛋白偶联受体信号通路”中富集。此外,还鉴定了 9 个核心 miRNA(hsa-mir-124、hsa-let-7、hsa-mir-155、hsa-mir-26a、hsa-mir-941、hsa-mir-10b、hsa-mir-20、hsa-mir-31 和 hsa-mir-372)和 2 个核心 TF(SP1 和 TERT),它们在瘢痕疙瘩形成中发挥重要作用。在 TF/miRNA-靶基因网络中,hsa-mir-372 和 hsa-mir-20 对 GNG13 均有调节作用,hsa-mir-10b 预测为 ADCY8 的靶基因,HTR1A 和 NPY 可能由 SP1 调节。此外,在临床样本中验证了核心调控基因(GNG13、ADCY8、HTR1A 和 NPY)的表达。
GNG13、ADCY8、NPY 和 HTR1A 可能作为瘢痕疙瘩形成的核心基因,这些核心基因与 SP1 和 miRNA(hsa-mir-372、hsa-mir-20、hsa-mir-10b)建立关系,可能影响瘢痕疙瘩发病机制中的多个信号通路。